FDA takes actions on Darvon, Darvocet and other pain medications containing Propoxyphene. Read more on http://s7y.us/10ft

Merck and Portola signed a license agreement for development and commercialization of betrixaban, an oral coagulation factor Xa inhibitor

Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth. Read more on http://tiny.cc/K74Sl

New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP. http://tiny.cc/geZLE

The Endocrine Society Responds to Recent Insulin Glargine Study with Recommendations for Patients and Physicians. http://tiny.cc/T4stl

Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis. Read more on http://sturly.com/ahno

The US Food and Drug Administration (FDA) has approved Tekturna HCT®. Read more on http://sturly.com/ahnp

European Commission approves broader label for Avastin. Read more on http://sturly.com/ahnr

Xeloda in combination with oxaliplatin shown to be effective in early colon cancer. Read more on http://sturly.com/ahns

Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab). Read more on http://sturly.com/ahnu

FDA: Cancer Warnings Required for TNF Blockers. Read more on http://ow.ly/jvkM

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers. Read more on http://ow.ly/jvkh

Boehringer Ingelheim to commence Phase III study investigating the role of BIBW 2992 (Tovok™). More on http://ow.ly/jvld

Afinitor® approved in EU as first treatment proven to benefit patients with advanced kidney cancer. Read more on http://ow.ly/jvlB

European Commission Approves Genzyme's Mozobil (plerixafor injection) for patients with lymphoma and multiple myeloma. http://ow.ly/jvm

Denosumab increases BMD and decreases vertebral fractures in men receiving androgen-deprivation therapy for prostate CA. http://ow.ly/kwdW

Denosumab for 36 months decreases risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis. More on http://ow.ly/kwej

Vectibix(R) Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic CRC. More on http://ow.ly/kweS

Orphan Drug Designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). More on http://ow.ly/kwfo

Avastin plus commonly used chemotherapies improves progression-free survival in women with HER2 negative breast cancer. http://ow.ly/kwgO